Profluent
About Profluent
Profluent is a company that specializes in protein design using AI. They aim to decode the language of life with their technology.
Recent News
Profluent Announces $106M Funding Round
STAT+: Boehringer’s Obesity Drug Shows 16.6% Weight Loss; More Data Needed
AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development
Eli Lilly Acquires Engage Biologics for ~$202M
Nathan Benaich's Air Street Raises $232M Fund III, Becoming Europe’s Largest Solo GP Venture Firm
Eli Lilly Inks AI Partnership with Profluent, Eyeing $2.25 B in Gene‑editing Milestones
Top Biotech Deals in April 2026
Eli Lilly Inks $2.25 B Profluent Deal to Fast‑track AI‑driven Gene‑therapy Platform
Eli Lilly Inks $2.25 B AI‑driven Drug Discovery Pact with Profluent